Evidence map›Paper›PMID 33396692›Full record

ArticleCancers2020

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea.

E Hwa Yun, Seri Hong, Eun Young Her, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

E Hwa YunNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.
Seri HongNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.
Eun Young HerNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.
Bomi ParkNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.
Mina SuhNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.
Kui Son ChoiNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.ORCID 0000-0001-5336-3874
Jae Kwan JunNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Goyang 10408, Korea.ORCID 0000-0003-1647-0675
National Cancer Center · KR

Funding

National Cancer Center #1910233-2
6 · The paper itself

Abstract

The study aimed to describe the participation rates of the National Cancer Screening Program (NCSP) among cancer survivors in Korea. The NCSP protocol recommends that all Korean men and women should be screened for cancer. Cancer survivors were defined as those registered for any cancer in the Korea Central Cancer Registry by December 31 of the year prior to being included in the target population of the NCSP. In this study, the participation rates for the NCSP were calculated as the percentage of people who participated in four kinds of cancer screening programs, independently. The average annual percentage change was assessed. The participation rates of the general population and cancer survivors were higher than 40% in stomach, breast, and cervical cancer screening. These rates were higher than that of colorectal cancer screening in 2014. In addition, the participation rates in the NCSP in 2002-2014 increased for all cancer types. The NCSP participation rates of the cancer survivors indicate the high demand for cancer screening. Further research may investigate the effect of the NCSP on second cancer occurrence or mortality in cancer survivors and the significance of cancer screening guidelines for cancer survivors.

Indexed as

cancercancer screeningcancer survivor

Identifiers

PMID33396692
PMCPMC7796127
OpenAlexW3116513367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.